In conclusion, our study implied that upregulation of IDO in breast cancer cells might inhibit local immune surveillance by favoring amplification and infiltration of CD4+CD25+ Tregs in the tumor microenvironment and thus promote metastasis and relate to a bad prognosis. Here, IDO1 is linked to breast carcinoma.